GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » Earnings per Share (Diluted)

Eisai Co (TSE:4523) Earnings per Share (Diluted) : 円168.38 (TTM As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Eisai Co Earnings per Share (Diluted)?

Eisai Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円20.81. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

Eisai Co's EPS (Basic) for the three months ended in Dec. 2023 was 円20.81. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

Eisai Co's EPS without NRI for the three months ended in Dec. 2023 was 円20.81. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

During the past 12 months, Eisai Co's average EPS without NRIGrowth Rate was 79.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -51.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -30.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.70% per year.

During the past 13 years, Eisai Co's highest 3-Year average EPS without NRI Growth Rate was 64.40% per year. The lowest was -51.50% per year. And the median was 1.60% per year.


Eisai Co Earnings per Share (Diluted) Historical Data

The historical data trend for Eisai Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Earnings per Share (Diluted) Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 884.48 1,699.20 585.16 167.25 193.31

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.14 56.92 70.92 19.73 20.81

Competitive Comparison of Eisai Co's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's PE Ratio falls into.



Eisai Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Eisai Co's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2023 is calculated as

Diluted Earnings Per Share (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(55432-0)/286.761
=193.30

Eisai Co's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(5969-0)/286.833
=20.81

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円168.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Eisai Co  (TSE:4523) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Eisai Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Eisai Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Eisai Co (TSE:4523) Business Description

Traded in Other Exchanges
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines